Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ABCB1 | P08183 | 17/20 | 0.53 |
| ▸ | ABCG2 | Q9UNQ0 | 14/20 | 0.52 |
| ▸ | CA12 | O43570 | 3/20 | 0.44 |
| ▸ | CA9 | Q16790 | 3/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL116992 | 0.83 | ABCB1 (0.53) | ABCB1ABCG2CA12CA9 | |
| SCHEMBL15910310 | 0.80 | TSHR (0.58) | ABCB1CA12CA9 | |
| Ammonia Solution, Strong SCHEMBL15940166 | 0.80 | TSHR (0.59) | ABCB1ABCG2CA12CA9 | |
| SCHEMBL10035133 | 0.79 | TSHR (0.48) | ABCB1ABCG2CA12CA9 | |
| SCHEMBL14440745 | 0.79 | KDM4E (0.50) | ABCB1ABCG2CA12CA9 | |
| SCHEMBL18404966 | 0.78 | CA12 (0.51) | ABCB1ABCG2CA12CA9 | |
| SCHEMBL14440746 | 0.78 | THRB (0.51) | ABCB1ABCG2CA12CA9 | |
| SCHEMBL3400661 | 0.77 | TDP1 (0.69) | — | |
| SCHEMBL17311277 | 0.77 | CA12 (0.49) | ABCB1ABCG2CA12CA9 | |
| SCHEMBL6880564 | 0.77 | ALDH1A1 (0.56) | ABCB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8808960-B2 | Compound and chemically amplified positive resist composition | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2014-08-19 | — | — | US | disclosed |
| US-20100233628-A1 | COMPOUND AND CHEMICALLY AMPLIFIED POSITIVE RESIST COMPOSITION | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2010-09-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100233628-A1 | COMPOUND AND CHEMICALLY AMPLIFIED POSITIVE RESIST COMPOSITION | HRH3, C9, H1-2 | ABCB1 1645/4885ABCG2 1610/4885CA12 1394/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.